Intravitreal dexamethasone implant (Ozurdex) in coats' disease

Creative Commons License

SAATCİ A. O., Doruk H. C., YAMAN A.

Case Reports in Ophthalmology, cilt.4, sa.3, ss.122-128, 2013 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 3
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1159/000355363
  • Dergi Adı: Case Reports in Ophthalmology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.122-128
  • Anahtar Kelimeler: Coats' disease, Dexamethasone implant, Laser photocoagulation, Ranibizumab
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashion. The dexamethasone implant seems to be a valuable addition to the armamentarium of treatment options for Coats' disease as it necessitates fewer injections than anti-VEGF injections and thereby fewer sessions of general anesthesia in the pediatric population. © 2013 S. Karger AG, Basel.